Prof Claudine Bonder
Research Professor
Centre for Cancer Biology
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Professor Claudine Bonder OAM is an expert in vascular biology with 25 years experience having trained both in Australia and overseas. She currently heads the Vascular Biology and Cell Trafficking Laboratory at the Centre for Cancer Biology in Adelaide. During her career, Claudine has been awarded the prestigious Early Career Research Award from the Australian Academy of Sciences in 2005, a SA Young Tall Poppy in 2010, was an ASMR Leading Light finalist in 2013, won the Women in Innovation (emerging innovator) in 2016 and in 2025 was awarded a Medal of the Order of Australia.
Research Program Overview:
Blood vessels form an extensive network that transports cells, oxygen and nutrients throughout all tissues and organs. Blood vessels are key components in our fight against disease and improved understanding of endothelial cells (ECs, specialised cells which form the inner lining of blood vessels), will provide new knowledge and novel treatment options for many fatal diseases, including cancer, heart disease and diabetes.
We have world leading research in vasculogenic mimicry (VM), a process wherein cancer cells themselves form vascular-like structures to increase access to the blood supply to assist in tumour growth. In the most aggressive and difficult to treat cancers of the breast, skin and pancreas, increased VM is associated with poor clinical outcome. We have begun to identify novel elements in VM and are now targeting these with an overall aim to provide better outcomes for cancer patients.
Current Research Projects:
Investigating the role of desmoglein-2 in the progression of blood cancers and solid tumours
Understanding the contribution of vasculogenic mimicry in the tumour microenvironment and cancer progression
Defining the gene expression, signalling pathways and spatial proteomics that promote and modulate tumour vasculature and anti-tumour immunity
Advancing CAR-T cells for application to combat solid tumours (Carina Biotech Ltd)
Our expertise in blood vessels, and the endothelial cells which form their inner lining, allows us to critically interrogate diseases such as cancer, cardiovascular disease and diabetes. Our ultimate aim is to understand the fundamental biology of the blood vasculature so that new treatment opportunities for the most debilitating and deadly diseases can be produced to save thousands of lives every year, worldwide.
| Year | Citation |
|---|---|
| 2006 | Bonder, C. S., & Kubes, P. (2006). Capture and Rolling: Selectins and Their Ligands. In A. Hamann, & B. Engelhardt (Eds.), Leukocyte Trafficking Molecular Mechanisms Therapeutic Targets and Methods (pp. 14-35). BLACKWELL SCIENCE PUBL. DOI Scopus1 WoS2 |
| Year | Citation |
|---|---|
| 2024 | Foeng, J., Tyllis, T., Abbott, C., McPeake, D., Thompson, E., Bandara, V., . . . McColl, S. (2024). Preclinical in vivo characterization underpinning LGR5-targeting CAR-T cells as a cancer immunotherapy. In CANCER RESEARCH Vol. 84 (pp. 2 pages). CA, San Diego: AMER ASSOC CANCER RESEARCH. DOI |
| 2023 | Bandara, V., Gundsambuu, B., Napoli, S., Foeng, J., McPeake, D., Tylis, T., . . . Barry, S. (2023). From bench to bedside: GMP manufacturing and testing of an LGR5-targeting CAR-T against colorectal cancer. In CANCER RESEARCH Vol. 84 (pp. 2 pages). CA, San Diego: AMER ASSOC CANCER RESEARCH. DOI WoS1 |
| 2023 | Liyanage, S., Williamson, A., Salagaras, T., Hassanshahi, M., Long, A., Tran, D., . . . Psaltis, P. (2023). Inhibitory And Metabolic Effects Of Diabetes On Yolk Sacderived Endothelial-macrophage Progenitors In Postnatal Murine Tissues. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 43 (pp. 2 pages). PA, Philadelphia: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2023 | Tyllis, T., Abbott, C., McPeake, D., Foeng, J., Bandara, V., Gundsambuu, B., . . . McColl, S. (2023). Development of a flow cytometry-based assay for measuring specific CAR expression on LGR5-targeting CAR-T cells. In CANCER RESEARCH Vol. 83 (pp. 2 pages). Orlando, FL: AMER ASSOC CANCER RESEARCH. DOI |
| 2023 | Bandara, V., Gundsambuu, B., Napoli, S., Mills, S., Thompson, E., Tan, L., . . . Barry, S. C. (2023). Development and in vitro validation of an LGR-5 targeting CAR-T against colorectal cancer. In CANCER RESEARCH Vol. 83 (pp. 2 pages). Orlando, FL: AMER ASSOC CANCER RESEARCH. DOI WoS1 |
| 2023 | Thompson, E. J., Bandara, V., Gundsambuu, B., Napoli, S., Mills, S., Foeng, J., . . . Bonder, C. S. (2023). Assessing LGR5 expression levels on colorectal cancer tissue samples for use in LGR5-targeting CAR-T cell therapy clinical trial. In CANCER RESEARCH Vol. 83 (pp. 2 pages). Orlando, FL: AMER ASSOC CANCER RESEARCH. DOI WoS1 |
| 2022 | Bandara, V., Mills, S., Thompson, E., Tan, L., Gundsambuu, B., Napoli, S., . . . Barry, S. (2022). Pre-clinical validation of a LGR5-targeting CAR-T against colorectal cancer.. In CANCER RESEARCH Vol. 82 (pp. 1 page). LA, New Orleans: AMER ASSOC CANCER RESEARCH. |
| 2022 | Thompson, E. J., Bandara, V., Sadlon, T., Gundsambuu, B., Tan, L. Y., Ricciardelli, C., . . . Bonder, C. S. (2022). Real-time cytotoxicity assays as a pre-clinical screening tool for LGR5-targeting CAR-T cells for treatment of solid tumors. In CANCER RESEARCH Vol. 82 (pp. 1 page). LA, New Orleans: AMER ASSOC CANCER RESEARCH. |
| 2022 | Thompson, E. J., Bandara, V., Sadlon, T., Gundsambuu, B., Tan, L. Y., Ricciardelli, C., . . . Bonder, C. S. (2022). Real-time cytotoxicity assays as a pre-clinical screening tool for LGR5-targeting CAR-T cells for treatment of solid tumors.. In CANCER RESEARCH Vol. 82 (pp. 1 page). LA, New Orleans: AMER ASSOC CANCER RESEARCH. |
| 2022 | Bandara, V., Mills, S., Thompson, E., Tan, L., Gundsambuu, B., Napoli, S., . . . Barry, S. (2022). Pre-clinical validation of a LGR5-targeting CAR-T against colorectal cancer. In CANCER RESEARCH Vol. 82 (pp. 1 page). LA, New Orleans: AMER ASSOC CANCER RESEARCH. |
| 2020 | Maiolo, S., Savaglia, J., Harper, R., Greening, D., Bonder, C., & Reynolds, P. (2020). THE EFFECT OF PAH AND CONTROL OUTGROWTH ENDOTHELIAL CELL EXOSOME TREATMENT ON ENDOTHELIAL CELL PROTEIN EXPRESSION. In RESPIROLOGY Vol. 25 (pp. 198). WILEY. |
| 2020 | Savaglia, J., Maiolo, S., Greening, D., Bonder, C., & Reynolds, P. (2020). EXOSOMES FROM PULMONARY ARTERIAL HYPERTENSION PATIENT AND CONTROL OUTGROWTH ENDOTHELIAL CELLS CAUSE DIFFERENT PROTEIN CHANGES TO SMOOTH MUSCLE CELLS IN VITRO. In RESPIROLOGY Vol. 25 (pp. 108). WILEY. |
| 2019 | Flemming, J. P., Haque, M., Daniels, S., Trofa, M., Raad, J., Bonder, C., . . . Mahoney, M. G. (2019). Tumorigenesis mediated by extracellular vesicles through a Dsg2/miR-146a/IL-8 signaling axis. In JOURNAL OF INVESTIGATIVE DERMATOLOGY Vol. 139 (pp. S291). FRANCE, Bordeaux: ELSEVIER SCIENCE INC. DOI |
| 2019 | Maiolo, S., Cockshell, M., Seyfang, J., Bonder, C., Harper, R., & Reynolds, P. (2019). FUNCTIONAL DIFFERENCES IN OUTGROWTH ENDOTHELIAL CELLS FROM PULMONARY ARTERIAL HYPERTENSION PATIENTS UNDER HYPOXIA. In RESPIROLOGY Vol. 24 (pp. 96). WILEY. |
| 2018 | Harper, R., Maiolo, S., Lim, R., Greening, D., Cockshell, M., Bonder, C., & Reynolds, P. (2018). EXOSOMES AND PAH: THE ROLE OF CELLULAR COMMUNICATION IN BOTH DISEASE PROGRESSION AND THERAPEUTIC SUCCESS. In RESPIROLOGY Vol. 23 (pp. 50). WILEY. |
| 2018 | Maiolo, S., Cockshell, M., Bonder, C., Harper, R., & Reynolds, P. (2018). CHARACTERISATION OF PULMONARY ARTERIAL HYPERTENSION ENDOTHELIAL PROGENITOR CELLS UNDER HYPOXIA. In RESPIROLOGY Vol. 23 (pp. 51). WILEY. |
| 2018 | Harper, R. L., Maiolo, S. A., Cockshell, M., Lim, R., Greening, D. W., Bonder, C. S., & Reynolds, P. N. (2018). The Role of Peripheral Blood Derived Outgrowth Endothlial Cells and Their Exosomes in the Progression and Treatment of Pulmonary Arterial Hypertension. In MOLECULAR THERAPY Vol. 26 (pp. 352-353). Chicago, IL: CELL PRESS. |
| 2018 | Harper, R., Maiolo, S., Cockshell, M., Bonder, C., & Reynolds, P. (2018). Functional changes in peripheral blood derived outgrowth endothelial progenitor cells from PAH patients in response to hypoxia. In EUROPEAN RESPIRATORY JOURNAL Vol. 52 (pp. 1 page). Paris, FRANCE: EUROPEAN RESPIRATORY SOC JOURNALS LTD. DOI |
| 2017 | Harper, R., Cockshell, M., Bonder, C., & Reynolds, P. (2017). Characteristics and utility of exosomes obtained from peripheral blood derived endothelial progenitor cells of PAH patients. In EUROPEAN RESPIRATORY JOURNAL Vol. 50 (pp. 1 page). ITALY, Milan: EUROPEAN RESPIRATORY SOC JOURNALS LTD. DOI |
| 2017 | Harper, R., Maiolo, S., Cockshell, M., Bonder, C., & Reynolds, P. (2017). BIO-DISTRIBUTION OF EPCS IN DISEASE AND THE POTENTIAL ROLE OF EXOSOMES IN CELL THERAPY FOR PULMONARY VASCULAR DISEASES. In RESPIROLOGY Vol. 22 (pp. 76). WILEY. |
| 2017 | Harper, R., Cockshell, M., Bonder, C., & Reynolds, P. (2017). Isolation of Exosomes from Peripheral Blood Derived Endothelial Progenitor Cells of PAH and Control Subjects with Analysis of Their Surface Markers. In MOLECULAR THERAPY Vol. 25 (pp. 286). DC, Washington: CELL PRESS. |
| 2016 | Cockshell, M., Harding, E., Dalilottojari, A., Delalat, B., Voelcker, N., & Bonder, C. (2016). RAPID AND LARGE SCALE EXPANSION OF HUMAN ENDOTHELIAL PROGENITOR CELLS WITH THERAPEUTIC POTENTIAL. In CYTOTHERAPY Vol. 18 (pp. S20). ELSEVIER SCI LTD. DOI WoS1 |
| 2016 | Tan, L., Sachi, P., Brown, M., Bonder, C., & Ebert, L. (2016). The role of vasculogenic mimicry vessels in mediating leukocyte recruitment to melanomas. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 212-213). AUSTRALIA, Melbourne: WILEY-BLACKWELL. |
| 2016 | Harper, R., Ward, R., Bonder, C., & Reynolds, P. (2016). SMAD SIGNALLING PROFILES ARE ALTERED FOLLOWING BMPR2 AUGMENTED EPC DELIVERY IN A RAT MONOCROTALINE INDUCED PAH MODEL. In RESPIROLOGY Vol. 21 (pp. 89). WILEY-BLACKWELL. |
| 2016 | Harper, R. L., Bonder, C. S., & Reynolds, P. N. (2016). BMPR2 Augmented EPC Delivery in a Rat Monocrotaline Induced PAH Model Alters Smad Signalling Profiles. In Proceedings of the American Thoracic Society. San Francisco. |
| 2016 | Bonder, C., Min, M. K. K., Parham, K., Rojas-Canales, D., Penko, D., Drogemuller, C., & Coates, P. T. (2016). Revealing a critical cross-talk between beta islet cells and the vasculature in diabetes. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 550). Melbourne, AUSTRALIA: WILEY-BLACKWELL. |
| 2016 | Ebert, L., Tan, L. Y., Min, K. K. M., Cockshell, M., Johan, M. Z., Parham, K., . . . Bonder, C. (2016). Desmoglein 2 (DSG2) is a novel surface marker of endothelial and haematopoietic progenitor cells, and plays a critical role in neoangiogenesis. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 309). Melbourne, AUSTRALIA: WILEY-BLACKWELL. |
| 2015 | Harper, R. L., Ward, R., Bonder, C. S., & Reynolds, P. N. (2015). Smad and Non Smad Signalling in PAH Following BMPR2 Gene Delivery. In Proceedings of the American Thoracic Society. Denver, CO, US: American Thoracic Society. |
| 2015 | Rojas-Canales, D., Penko, D., Peiris, H., Keating, D., Pitson, S., Drogemuller, C. J., . . . Jessup, C. J. (2015). SPHINGOSINE KINASE 1 IS VITAL FOR THE FUNCTION OF ISLETS POST TRANSPLANTATION.. In TRANSPLANTATION Vol. 99 (pp. S225). Melbourne, AUSTRALIA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2015 | Min, K. K. M., Parham, K. A., Rojas-Canales, D., Penko, D., Drogemuller, C., Coates, T., & Bonder, C. (2015). REVEALING A CRITICAL CROSS-TALK BETWEEN BETA ISLET CELLS AND THE VASCULATURE IN DIABETES. In TRANSPLANTATION Vol. 99 (pp. S293). Melbourne, AUSTRALIA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2015 | Min, K. K. M., Parham, K. A., Rojas-Canales, D., Penko, D., Drogemuller, C., Coates, T., & Bonder, C. (2015). Revealing a critical cross-talk between beta islet cells and the vasculature in diabetes. In XENOTRANSPLANTATION Vol. 22 (pp. S176). Melbourne, AUSTRALIA: WILEY-BLACKWELL. |
| 2015 | Rojas-Canales, D., Penko, D., Peiris, H., Keating, D., Pitson, S., Drogemuller, C. J., . . . Jessup, C. J. (2015). Sphingosine kinase 1 is vital for the function of islets post transplantation. In XENOTRANSPLANTATION Vol. 22 (pp. S136). Melbourne, AUSTRALIA: WILEY-BLACKWELL. |
| 2015 | Harper, R. L., Bonder, C. S., & Reynolds, P. N. (2015). Up-regulation of BMPR2 in Rat Derived Endothelial Progenitor Cells Leads to the Attenuation of PAH in a MCT Rat Model. In Proceedings of the American Thoracic Society. Denver, CO, US: American Thoracic Society. |
| 2014 | Harper, R., Bonder, C., & Reynolds, P. (2014). ISOLATION AND CHARACTERIZATION OF A DEFINED POPULATION OF ENDOTHELIAL PROGENITOR CELLS FROM THE LEFT VENTRICLE: A PILOT STUDY. In RESPIROLOGY Vol. 19 (pp. 95). WILEY-BLACKWELL. |
| 2014 | Penko, D., Peiris, H., Rojas-Canales, D., Mohanasundaram, D., Drogemuller, C., Coates, P., . . . Jessup, C. (2014). Endothelial Progenitor Cell (EPC) Co-Transplantation Enhances the Engraftment of Pancreatic Islets and Influences Beta Cell Function <i>In Vitro</i>.. In AMERICAN JOURNAL OF TRANSPLANTATION Vol. 14 (pp. 359). San Francisco, CA: WILEY-BLACKWELL. DOI |
| 2014 | Penko, D., Peiris, H., Rojas-Canales, D., Mohanasundaram, D., Drogemuller, C., Coates, P., . . . Jessup, C. (2014). Endothelial Progenitor Cell (EPC) Co-Transplantation Enhances the Engraftment of Pancreatic Islets and Influences Beta Cell Function <i>In Vitro</i>. In TRANSPLANTATION Vol. 98 (pp. 359). San Francisco, CA: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2012 | Sun, W. Y., Abeynaik, L., Pitson, S., Hickey, M., & Bonder, C. (2012). SPHINGOSINE KINASE-1 REGULATES P-SELECTIN EXPRESSION AND NEUTROPHIL RECRUITMENT DURING ALLERGIC INFLAMMATION. In INTERNAL MEDICINE JOURNAL Vol. 42 (pp. 12-13). WILEY-BLACKWELL. |
| 2011 | Penko, D., Mee, C., Mohanasundaram, D., Coates, P. T. H., Bonder, C. S., & Jessup, C. F. (2011). INCORPORATION OF RAT VASCULAR PROGENITOR CELLS INTO MOSAIC ISLET CLUSTERS. In IMMUNOLOGY AND CELL BIOLOGY Vol. 89 (pp. A34). ANU Campus, Canberra, AUSTRALIA: NATURE PUBLISHING GROUP. |
| 2011 | Penko, D., Mee, C., Mohanasundaram, D., Coates, P., Bonder, C., & Jessup, C. (2011). Incorporation of rat vascular progenitor cells into mosaic islet clusters to promote engraftment of transplanted pancreatic islets. In 13th World Congress of the International Pancreas and Islet Transplant Association (pp. 0 pages). Prague, Czech Republic. |
| 2009 | Jessup, C. F., Mohanasundaram, D., Mee, C., Sun, W. Y., Drogemuller, C., Milner, C. R., . . . Coates, P. T. H. (2009). Co-transplantation of rat endothelial progenitor cells to enhance the engraftment of pancreatic islets. In XENOTRANSPLANTATION Vol. 16 (pp. 412). Venice, ITALY: WILEY-BLACKWELL PUBLISHING, INC. |
| 2003 | Liu, L. X., Zbytnuik, L., Andonegui, G., Bonder, C., Kerfoot, S. M., & Kubes, P. (2003). Exogenous SDF-1a induces leukocyte recruitment in mice. In FASEB JOURNAL Vol. 17 (pp. A1071). CALIFORNIA, SAN DIEGO: FEDERATION AMER SOC EXP BIOL. |
| 2003 | Bonder, C. S., Kerfoot, S. M., Zbytnuik, L. D., Weaver, C., Bullard, D., & Kubes, P. (2003). T helper (Th) 1 dominated inflammation in a variety of organs recruit both Th1 and Th2 cells via different mechanisms. In FASEB JOURNAL Vol. 17 (pp. A797). CALIFORNIA, SAN DIEGO: FEDERATION AMER SOC EXP BIOL. |
| 2003 | Bonder, C. S., Ajuebor, M. N., Zbytnuik, L. D., Kubes, P., & Swain, M. G. (2003). Neutrophil recruitment in Concavalin A (ConA)-induced hepatitis. In FASEB JOURNAL Vol. 17 (pp. A252). CALIFORNIA, SAN DIEGO: FEDERATION AMER SOC EXP BIOL. |
| 1998 | Hart, P. H., Bonder, C. S., Dickenshets, H. L., Finlay-Jones, J. J., & Donnelly, R. P. (1998). γ<sub>c</sub> and the control by IL-4 of human macrophage proinflammatory mediator production.. In FASEB JOURNAL Vol. 12 (pp. A298). FEDERATION AMER SOC EXP BIOL. |
| 1996 | Hart, P. H., Bonder, C. S., & FinlayJones, J. J. (1996). An IL-4 mutant protein is both an IL-4-agonist and antagonist in regulating the inflammatory activity of human blood monocytes. In JOURNAL OF LEUKOCYTE BIOLOGY (pp. 24). FEDERATION AMER SOC EXP BIOL. |
| Year | Citation |
|---|---|
| 2017 | Lopez, A. F., Bonder, C. S., & Thompson, E. (2017). WO2017027898, Novel cancer treatment involving modulation of il-3 activity. |
| 2017 | Moore, E., Benveniste, G. L., & Bonder, C. S. (2017). WO2017156593, Medical devices using coated polymers. |
| 2016 | Voelcker, N. H., Moore, E., & Bonder, C. S. (2016). AU2016901008, Anti-fouling and/or anti-thrombotic medical devices. |
| 2015 | Bonder, C. S., & Lopez, A. F. (2015). WO2015168750, Method of culturing cells. |
| 2013 | Bonder, C. S., López, Á. F., & Talbo, G. H. (2013). EP2635674, Markers of endothelial progenitor cells and uses thereof. |
| Year | Citation |
|---|---|
| 2016 | Harper, R. L. (2016). Gene therapy for Pulmonary Arterial Hypertension with Bone Morphogenetic Protein Receptor Type-2 modulation via engineered endothelial progenitor cells or a targeted Adeno-viral construct: changes in Smad and non-Smad signalling contributed to amelioration of disease. |
| Year | Citation |
|---|---|
| 2026 | Ortiz, M., Ffrench, C., Webb, S., Toubia, J., Nataren, N., Dorward, E., . . . Bonder, C. (2026). Tumor Protein D54 (TPD54) regulates intracellular protein trafficking, cellular function and disease progression in melanoma. DOI |
| 2025 | Liu, J., Geremew, D., Sandeman, L. Y., Nankivell, V. A., Chen, R., Xiang, L., . . . Bursill, C. A. (2025). Development of a novel murine model of in-stent neoatherosclerosis. DOI |
| 2021 | Martini, C., DeNichilo, M., King, D., Cockshell, M., Ebert, B., Dale, B., . . . Bonder, C. (2021). CD36 Promotes Vasculogenic Mimicry in Melanoma by Mediating Adhesion to the Extracellular Matrix. DOI |
-
Advancing a new targeted antibody to combat pancreatic cancer, PanKind Australia - New Treatment Grant, 16/12/2024 - 31/01/2027
-
Enhancing the entry of therapeutic CAR-T cells into brain tumours, Neurosurgical Research Foundation, 01/08/2025 - 30/01/2027
-
CRC-P: Internal Testing and assessment of CAR-T cells using in vitro methods and in vivo animal tumour models, UniSA-Internal, 29/02/2020 - 30/06/2026
-
Exploiting blood vessels as conduits for the entry of therapeutic CAR-T cells into brain tumours, Neurosurgical Research Foundation, 02/10/2023 - 31/10/2025
-
MTA_ATCC - Spatial proteomics to define tumour microenvironments , Unknown, 11/10/2022 - 11/10/2024
-
Desmoglein-2; an unsuspected regulator of melanoma, NHMRC - Project Grant, 01/01/2019 - 31/12/2022
-
Investigating a novel adhesion molecule in pancreatic cancer, PanKind Australia - New Treatment Grant, 01/01/2022 - 31/10/2022
-
Engineered cell and exosome therapy for pulmonary vascular disease, NHMRC - Project Grant, 01/01/2018 - 31/12/2021
-
Targeting the IL-3/IL-3 receptor axis to prevent breast cancer progression., CA-Priority-driven Collaborative Cancer Research Scheme, 01/05/2016 - 31/03/2020
-
Desmoglein-2: A novel lifeline to treat diabetes, NHMRC - Project Grant, 01/01/2016 - 31/12/2019
-
Validation of a novel therapeutic target in multiple myeloma, Royal Adelaide Hospital, 01/01/2016 - 31/03/2017
-
Checkpoint blockade immunotherapy in melanoma: getting tumour-killing T cells to their site of action, Royal Adelaide Hospital, 01/01/2016 - 31/03/2017
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Co-Supervisor | 642 - Investigating causes of congenital heart and vascular defects | Master of Research (Medical Science) | Master | Full Time | Ms Briarn Elizabeth Dixon |
| 2025 | Co-Supervisor | 642 - Investigating causes of congenital heart and vascular defects | Master of Philosophy | Master | Full Time | Ms Briarn Elizabeth Dixon |
| 2024 | Principal Supervisor | Investigating the origins and progression of pancreatic cancer | Doctor of Philosophy | Doctorate | Full Time | Miss Emma Luise Dorward |
| 2023 | Co-Supervisor | 110188-Enhancing therapy of acute myeloid leukaemia by predicting drivers of relapse | Doctor of Philosophy | Doctorate | Full Time | Ms Leeann Nicole Desouza |
| 2023 | Co-Supervisor | Enhancing cancer immunotherapy success by efficient recruitment of T cells to solid tumours | Doctor of Philosophy | Doctorate | Full Time | Ms Resty Nabeeta |
| 2022 | Principal Supervisor | Molecular diagnosis for point-of-care skin cancer testing | Doctor of Philosophy | Doctorate | Part Time | Miss Nathalie Nataren |
| 2022 | Principal Supervisor | Advancing a novel biomarker for pancreatic cancer | Doctor of Philosophy | Doctorate | Full Time | Miss Charlie Ffrench |
| 2021 | Principal Supervisor | Tumour protein D54 as a regulator of melanoma progression | Doctor of Philosophy | Doctorate | Full Time | Mr Michael Ortiz |
| 2020 | Co-Supervisor | Deciphering how airway epithelial programming and inflammation cause chronic allergic airways disease | Doctor of Philosophy | Doctorate | Part Time | Ms Anita Kral |
| 2019 | Co-Supervisor | Characterisation of extracellular matrix composition across the human brain and applications in brain organoid vascularisation | Doctor of Philosophy | Doctorate | Part Time | Ms Kaitlin Grace Scheer |
| 2019 | Principal Supervisor | Revealing the role of ICAM1 in breast cancer progression | Doctor of Philosophy | Doctorate | Part Time | Ms Anahita Fouladzadeh |
| 2014 | Principal Supervisor | Regulation of vascular development in triple negative breast cancer, roles for interleukin-3 (IL-3) and inhibitor of DNA binding-1 (ID1). | - | Doctorate | Part Time | Miss Emma Thompson |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2021 - 2026 | Principal Supervisor | Tumour protein D54 as a regulator of melanoma progression | Doctor of Philosophy | Doctorate | Full Time | Michael Ortiz |
| 2021 - 2025 | Co-Supervisor | Understanding how cancers modify the functional characteristics of the tumour extracellular matrix | Doctor of Philosophy | Doctorate | Full Time | Dr Chun-Hsien Chen |
| 2019 - 2023 | Co-Supervisor | Inhibitory and metabolic effects of diabetes on yolk sac-derived endothelial-macrophage progenitors in postnatal murine tissues | Doctor of Philosophy | Doctorate | Full Time | Ms Sanuri Rashmitha Liyanage |
| 2019 - 2024 | Co-Supervisor | Targeting sphingosine kinase 1 to overcome venetoclax resistance in acute myeloid leukemia | Doctor of Philosophy | Doctorate | Full Time | Mr Gus Nwosu |
| 2019 - 2026 | Principal Supervisor | Revealing the role of ICAM1 in breast cancer progression | Doctor of Philosophy | Doctorate | Part Time | Mrs Anahita Fouladzadeh |
| 2018 - 2022 | External Supervisor | Discovery and characterisation of yolk-sac derived Endothelial-Macrophage progenitor cells in postnatal murine tissues | Doctor of Philosophy | Doctorate | Full Time | Miss Anna Emilie Williamson |
| 2018 - 2021 | Co-Supervisor | Targeting sphingolipid metabolism in proteasome inhibitor-resistant multiple myeloma | Doctor of Philosophy | Doctorate | Part Time | Miss Melissa Bennett |
| 2018 - 2023 | Principal Supervisor | Desmoglein-2 as a regulator of pancreatic ductal adenocarcinoma progression | Doctor of Philosophy | Doctorate | Full Time | Miss Kay Khine Myo Min |
| 2018 - 2020 | Co-Supervisor | Transcriptional control of cellular identity in the lymphatic vasculature | Doctor of Philosophy | Doctorate | Full Time | Ms Janette Kazenwadel |
| 2016 - 2020 | Co-Supervisor | Design and evaluation of blood-contacting coatings | Doctor of Philosophy | Doctorate | Full Time | Ms Anouck Burzava |
| 2015 - 2020 | Co-Supervisor | The role of flightless I in epidermal stem cell division, proliferation and differentiation during development, homeostasis, wound healing and epidermolysis bullosa-cutaneous squamous cell carcinoma | Doctor of Philosophy | Doctorate | Full Time | Mr Gink Yang |
| 2015 - 2020 | Co-Supervisor | Fundamental studies of poly(ethylene glycol-b-caprolactone) block copolymers self-assembly in water | Doctor of Philosophy | Doctorate | Full Time | Mr Khandokar Faisal |
| 2014 - 2026 | Principal Supervisor | Regulation of vascular development in triple negative breast cancer, roles for interleukin-3 (IL-3) and inhibitor of DNA binding-1 (ID1). | Doctor of Philosophy | Doctorate | Part Time | Miss Emma Thompson |
| 2014 - 2018 | Co-Supervisor | Vasculogenic mimicry: regulation and function in melanoma | Doctor of Philosophy | Doctorate | Full Time | Miss Lih Tan |
| 2014 - 2018 | Principal Supervisor | The role of platelets in vasculogenic mimicry | Doctor of Philosophy | Doctorate | Part Time | Miss Carmela Martino |
| 2012 - 2017 | Co-Supervisor | Roles and Regulation of Sphingosine Kinase 2 in Cancer | Doctor of Philosophy | Doctorate | Part Time | Heidi Anne Neubauer |
| 2012 - 2016 | Co-Supervisor | GENE THERAPY FOR PULMONARY ARTERIAL HYPERTENSION WITH BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-2 MODULATION VIA ENGINEERED ENDOTHELIAL PROGENITOR CELLS OR A TARGETED ADENO-VIRAL CONSTRUCT: CHANGES IN SMAD AND NON-SMAD SIGNALLING CONTRIBUTED TO AMELIORATION OF DISEASE | Doctor of Philosophy | Doctorate | Full Time | Ms Rebecca Lea Harper |
| 2010 - 2015 | Principal Supervisor | Sphingosine Kinase-1 Regulates Neutrophil Recruitment During Allergic Inflammation | Doctor of Philosophy | Doctorate | Full Time | Miss Wai Yan Sun |
| 2010 - 2015 | Principal Supervisor | Peroxisome proliferator-activated receptor gamma interacts with sphingosine 1-phosphate to regulate vascular function | Doctor of Philosophy | Doctorate | Part Time | Ms Kate Parham |
| 2007 - 2012 | Co-Supervisor | Endothelial Progenitor Cells, Uraemic Toxins and the Development of Endothelial Dysfunction in Chronic Kidney Disease | Doctor of Philosophy | Doctorate | Part Time | Dr Shaundeep Sen |
| 2006 - 2010 | Co-Supervisor | Regulation of Sphingosine Kinase by Interacting Proteins | Doctor of Philosophy | Doctorate | Full Time | Dr Tamara Leclercq |
Available For Media Comment.